Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000537829 | SCV000659502 | benign | Adams-Oliver syndrome 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315062 | SCV000739427 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2018-06-08 | criteria provided, single submitter | clinical testing | The p.P284L variant (also known as c.851C>T), located in coding exon 5 of the NOTCH1 gene, results from a C to T substitution at nucleotide position 851. The proline at codon 284 is replaced by leucine, an amino acid with similar properties. This alteration was detected in a proband and the proband's child with bicuspid aortic valve (Foffa I et al. BMC Med Genet. 2013;14:44). This variant was also detected in a patient with congenital heart disease as well as non-cardiac findings who also harbored other variants (Jin SC et al. Nat Genet. 2017;49(11):1593-1601). This amino acid position is not well conserved in available vertebrate species, and leucine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Ce |
RCV001815410 | SCV002063282 | uncertain significance | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000537829 | SCV002553977 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270714 | SCV002553978 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |